TVRD שיעור רווח גולמי Cara Therapeutics, Inc.

Cara Therapeutics Inc develops innovative selective agonists to combat renal pruritus. Competent management effectively engages with regulators, achieving its established goals. The gross profit margin helps assess the real value of the business, while 0.00 reflects the latest level of this metric. However, a reduction in research staff and the abandonment of several programs have limited internal development.
פילוחי מדדים פיננסיים ומדדי שוק עבור Cara Therapeutics Inc (TVRD)

Gross margin determines production efficiency by measuring the portion of revenue remaining after direct product creation costs. Analyzing the gross profit margin allows for an assessment of the financial stability of Cara Therapeutics Inc (TVRD), where patent protection and the chronic nature of kidney diseases ensure a stable cash flow and high profitability for each unit of the drug sold.